Compare ADXN & LUCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADXN | LUCY |
|---|---|---|
| Founded | 2002 | 2017 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3M | 7.3M |
| IPO Year | N/A | 2022 |
| Metric | ADXN | LUCY |
|---|---|---|
| Price | $7.74 | $1.00 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 6.7K | ★ 197.1K |
| Earning Date | 12-04-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $198,824.00 | ★ $2,392,547.00 |
| Revenue This Year | $86.57 | $80.76 |
| Revenue Next Year | N/A | $210.34 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 53.22 |
| 52 Week Low | $6.51 | $1.07 |
| 52 Week High | $12.05 | $7.08 |
| Indicator | ADXN | LUCY |
|---|---|---|
| Relative Strength Index (RSI) | 46.21 | 24.75 |
| Support Level | $7.66 | $1.36 |
| Resistance Level | $8.90 | $1.43 |
| Average True Range (ATR) | 0.43 | 0.10 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 38.62 | 6.84 |
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok.